Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 3 years.
Humacyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 9, 202684.7%
-
Humacyte Inc. June 7, 202391.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 2026 | Humacyte Inc. | Open-market purchase | +56,818 | $0.88 | $50,000 |
| Apr 8, 2025 | Humacyte Inc. | Open-market purchase | +50,000 | $1.32 | $66,000 |
| Sep 10, 2024 | Humacyte Inc. | Option exercise | +4,521 | $4.34 | $19,621 |
| Sep 10, 2024 | Humacyte Inc. | Open-market sale | −3,634 | $5.41 | $19,660 |
| Sep 10, 2024 | Humacyte Inc. | Option exercise | +2,479 | $3.35 | $8,305 |
| Sep 10, 2024 | Humacyte Inc. | Open-market sale | −1,548 | $5.39 | $8,344 |
| Jun 14, 2024 | Humacyte Inc. | Option exercise | +39,389 | $2.56 | $100,836 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.